Prophylactic Use of Enoxaparin in Adolescents During Bariatric Surgery-a Prospective Clinical Study.

Janelle D VaughnsVictoria C ZiesenitzElaine F WilliamsEvan P NadlerGerd MikusJohannes van den Anker

Published in: Obesity surgery (2020)

Our dosing scheme of 40 mg vs. 60 mg enoxaparin stratified according to BMI proved to be effective in reaching prophylactic anti-FXa activity in 83% of adolescent patients.

Keyphrases

bariatric surgery
young adults
venous thromboembolism
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
body mass index
physical activity
weight loss
prognostic factors
clinical trial
obese patients